Migraine in Pregnancy

ABSTRACT

Migraine is the headache disorder that most commonly complicates pregnancy. Migraine often, but not always, improves during pregnancy. Postdelivery migraine flares are common, and it can be difficult to distinguish these from dangerous causes of postpartum headache. Many pregnant or lactating migraineurs require intermittent use of medication for treatment of individual headache attacks, and some also need preventive treatment aimed at decreasing the number or severity of headache attacks. In general, medication use should be limited and nonpharmacologic approaches are preferred. Appropriate treatment choices also vary with the stage of pregnancy, and may differ for pregnancy and lactation. Risk rating systems are available that help guide decisions. Women with migraine have an increased risk for several serious pregnancy complications, but there is little convincing evidence of an increase in neonatal complications. Migraine is not a contraindication to breast-feeding.

Migraine - pregnancy - postpartum - lactation

REFERENCES

• 1 Lipton R B, Bigal M E. The epidemiology of migraine.  Am J Med. 2005;  118(suppl 1) 3S-10S
• 2 Lipton R B, Stewart W F, Diamond S, Diamond M L, Reed M. Prevalence and burden of migraine in the United States: data from the American migraine study II.  Headache. 2001;  41 646-657
• 3 Czeizel A E, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.  N Engl J Med. 1992;  327 1832-1835
• 4 Alsdorf R, Wyszynski D F. Teratogenicity of sodium valproate.  Expert Opin Drug Saf. 2005;  4 345-353
• 5 Amir B Y, Yaacov B, Guy B, Gad P, Itzhak W, Gal I. Headaches in women undergoing in vitro fertilization and embryo-transfer treatment.  Headache. 2005;  45 215-219
• 6 Parra J, Brocalero-Camacho A, Sancho J, Cervelló-Donderis A, Lacruz-Ballester L, Romero-Martínez A. Migrainous infarction and clomiphene citrate.  Rev Neurol. 2006;  42 572-574
• 7 Ertresvag J M, Zwart J A, Helde G, Johnsen H J, Bovim G. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort.  Acta Neurol Scand. 2005;  111 233-237
• 8 Mannix L K, Diamond M, Loder E. Women and headache: a treatment approach based on life stages.  Cleve Clin J Med. 2002;  69 488-500
• 9 Wainscott G, Sullivan F M, Volans G N, Wilkinson M. The outcome of pregnancy in women suffering from migraine.  Postgrad Med J. 1978;  54 98-102
• 10 Olesen C, Steffensen F H, Sorensen H T, Nielsen G L, Olsen J. Pregnancy outcome following prescription for sumatriptan.  Headache. 2000;  40 20-24
• 11 Banhidy F, Acs N, Horvath-Puho E, Czeizel A E. Maternal severe migraine and risk of congenital limb deficiencies.  Birth Defects Res A Clin Mol Teratol. 2006;  76 592-601
• 12 Banhidy F, Acs N, Horvath-Puho E, Czeizel A E. Pregnancy complications and delivery outcomes in pregnant women with severe migraine.  Eur J Obstet Gynecol Reprod Biol. 2006;  , November 8 (Epub ahead of print)
• 13 Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia.  Nat Clin Pract Nephrol. 2005;  1 98-114
• 14 Adeney K L, Williams M A. Migraine headaches and preeclampsia: an epidemiologic review.  Headache. 2006;  46 794-803
• 15 Adeney K L, Williams M A, Miller R S, Frederick I O, Sorensen T K, Luthy D A. Risk of preeclampsia in relation to maternal history of migraine headaches.  J Matern Fetal Neonatal Med. 2005;  18 167-172
• 16 Facchinetti F, Allais G, D'Amico R et al.. The relationship between headache and preeclampsia: a case-control study.  Eur J Obstet Gynecol Reprod Biol. 2005;  121 143-148
• 17 Marcoux S, Berube S, Brisson J, Fabia J. History of migraine and risk of pregnancy-induced hypertension.  Epidemiology. 1992;  3 53-56
• 18 Rubin P C, McCabe R. Postpartum migraine and severe pre-eclampsia.  Lancet. 1984;  2 285-286
• 19 Moore M P, Redman C W. Case-control study of severe pre-eclampsia of early onset.  Br Med J (Clin Res Ed). 1983;  287 580-583
• 20 Scher A I, Terwindt G M, Picavet H S, Verschuren W M, Ferrari M D, Launer L J. Cardiovascular risk factors and migraine: the GEM population-based study.  Neurology. 2005;  64 614-620
• 21 Chames M C, Livingston J C, Ivester T S, Barton J R, Sibai B M. Late postpartum eclampsia: a preventable disease?.  Am J Obstet Gynecol. 2002;  186 1174-1177
• 22 Veltkamp R, Kupsch A, Polasek J, Yousry T A, Pfister H W. Late onset postpartum eclampsia without pre-eclamptic prodromi: clinical and neuroradiological presentation in two patients.  J Neurol Neurosurg Psychiatry. 2000;  69 824-827
• 23 Headache Classification Subcommittee of the International Headache Society . The international classification of headache disorders. 2nd ed.  Cephalalgia. 2004;  24(suppl 1) 9-160
• 24 Altman D, Carroli G, Duley L et al.. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial.  Lancet. 2002;  359 1877-1890
• 25 Rozen T D. Aborting a prolonged migrainous aura with intravenous prochlorperazine and magnesium sulfate.  Headache. 2003;  43 901-903
• 26 Welch K M, Ramadan N M. Mitochondria, magnesium and migraine.  J Neurol Sci. 1995;  134 9-14
• 27 Seelig M S. Interrelationship of magnesium and estrogen in cardiovascular and bone disorders, eclampsia, migraine and premenstrual syndrome.  J Am Coll Nutr. 1993;  12 442-458
• 28 Ramadan N M, Halvorson H, Vande-Linde A, Levine S R, Helpern J A, Welch K M. Low brain magnesium in migraine.  Headache. 1989;  29 590-593
• 29 Kittner S J, Stern B J, Feeser B R et al.. Pregnancy and the risk of stroke.  N Engl J Med. 1996;  335 768-774
• 30 James A H, Bushnell C D, Jamison M G, Myers E R. Incidence and risk factors for stroke in pregnancy and the puerperium.  Obstet Gynecol. 2005;  106 509-516
• 31 Witlin A G, Mattar F, Sibai B M. Postpartum stroke: a twenty-year experience.  Am J Obstet Gynecol. 2000;  183 83-88
• 32 Somerville B W. Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration.  Neurology. 1975;  25 245-250
• 33 Rasmussen B K. Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle.  Pain. 1993;  53 65-72
• 34 Passchier J, Kaminsky M M, Paarlberg K M, van Geijn H P. Stress during pregnancy is unrelated to headache change in migraineurs.  Headache. 1996;  36 189
• 35 Granella F, Sances G, Pucci E, Nappi R E, Ghiotto N, Napp G. Migraine with aura and reproductive life events: a case control study.  Cephalalgia. 2000;  20 701-707
• 36 Scharff L, Marcus D A, Turk D C. Headache during pregnancy and in the postpartum: a prospective study.  Headache. 1997;  37 203-210
• 37 Lo W Y, Friedman J M. Teratogenicity of recently introduced medications in human pregnancy.  Obstet Gynecol. 2002;  100 465-473
• 38 Pregnancy categories for prescription drugs.  FDA Drug Bull. 1982;  12 24-25
• 39 Boothby L A, Doering P L. FDA labeling system for drugs in pregnancy.  Ann Pharmacother. 2001;  35 1485-1489
• 40 Friedman J M, Little B B, Brent R L, Cordero J F, Hanson J W, Shepard T H. Potential human teratogenicity of frequently prescribed drugs.  Obstet Gynecol. 1990;  75 594-599
• 41 Addis A, Sharabi S, Bonati M. Risk classification systems for drug use during pregnancy: are they a reliable source of information?.  Drug Saf. 2000;  23 245-253
• 42 Loder E. Safety of sumatriptan in pregnancy: a review of the data so far.  CNS Drugs. 2003;  17 1-7
• 43 Feniuk W, Humphrey P P, Perren M J. GR43175 does not share the complex pharmacology of the ergots.  Cephalalgia. 1989;  9(suppl 9) 35-39
• 44 Acs N, Banhidy F, Puho E, Czeizel A E. A possible dose-dependent teratogenic effect of ergotamine.  Reprod Toxicol. 2006;  22 551-552
• 45 Smets K, Zecic A, Willems J. Ergotamine as a possible cause of Möbius sequence: additional clinical observation.  J Child Neurol. 2004;  19 398
• 46 Hosking S P. Ergotamine use in pregnancy.  Aust N Z J Obstet Gynaecol. 1996;  36 159-160
• 47 Raymond G V. Teratogen update: ergot and ergotamine.  Teratology. 1995;  51 344-347
• 48 Needs C J, Brooks P M. Antirheumatic medication in pregnancy.  Br J Rheumatol. 1985;  24 282-290
• 49 Hermes-DeSantis E R, Clyman R I. Patent ductus arteriosus: pathophysiology and management.  J Perinatol. 2006;  26(suppl 1) S14-S18 discussion S22-S23
• 50 Ostrea Jr E M. Neonatal withdrawal from intrauterine exposure to butalbital.  Am J Obstet Gynecol. 1982;  143 597-598
• 51 Reinisch J M, Sanders S A, Mortensen E L, Rubin D B. In utero exposure to phenobarbital and intelligence deficits in adult men.  JAMA. 1995;  274 1518-1525
• 52 Holmes L B, Coull B A, Dorfman J, Rosenberger P B. The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs.  J Pediatr. 2005;  146 118-122
• 53 Yao M, Ritchie H E, Brown-Woodman P D. A reproductive screening test of feverfew: is a full reproductive study warranted?.  Reprod Toxicol. 2006;  22 688-693
• 54 Buckner K D, Chavez M L, Raney E C, Stoehr J D. Health food stores recommendations for nausea and migraines during pregnancy.  Ann Pharmacother. 2005;  39 274-279
• 55 Allena M, Magis D, Schoenen J. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines.  Neurology. 2005;  65 1339-1340
• 56 Shrim A, Boskovic R, Maltepe C, Navios Y, Garcia-Bournissen F, Koren G. Pregnancy outcome following use of large doses of vitamin B6 in the first trimester.  J Obstet Gynaecol. 2006;  26 749-751
• 57 Thaver D, Saeed M A, Bhutta Z A. Pyridoxine (vitamin B6) supplementation in pregnancy.  Cochrane Database Syst Rev. 2006;  (2) CD000179
• 58 Einarson A, Maltepe C, Navioz Y, Kennedy D, Tan M P, Koren G. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study.  BJOG. 2004;  111 940-943
• 59 Bsat F A, Hoffman D E, Seubert D E. Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy.  J Perinatol. 2003;  23 531-535
• 60 Gur C, Diav-Citrin O, Shechtman S, Arnon J, Ornoy A. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.  Reprod Toxicol. 2004;  18 93-101
• 61 Crowther C A, Harding J. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.  Cochrane Database Syst Rev. 2003;  (3) CD003935
• 62 Leung T N, Lam P M, Ng P C, Lau T K. Repeated courses of antenatal corticosteroids: is it justified?.  Acta Obstet Gynecol Scand. 2003;  82 589-596
• 63 Pfaffenrath V, Rehm M. Migraine in pregnancy: what are the safest treatment options?.  Drug Saf. 1998;  19 383-388
• 64 Buchanan T M, Ramadan N M. Prophylactic pharmacotherapy for migraine headaches.  Semin Neurol. 2006;  26 188-198
• 65 Marcus D A. Pregnancy and chronic headache.  Expert Opin Pharmacother. 2002;  3 389-393
• 66 Scharff L, Marcus D A, Turk D C. Maintenance of effects in the nonmedical treatment of headaches during pregnancy.  Headache. 1996;  36 285-290
• 67 Marcus D A, Scharff L, Turk D C. Nonpharmacological management of headaches during pregnancy.  Psychosom Med. 1995;  57 527-535
• 68 Sandor P S, Afra J. Nonpharmacologic treatment of migraine.  Curr Pain Headache Rep. 2005;  9 202-205
• 69 Wall V R. Breastfeeding and migraine headaches.  J Hum Lact. 1992;  8 209-212
• 70 Sances G, Granella F, Nappi R E et al.. Course of migraine during pregnancy and postpartum: a prospective study.  Cephalalgia. 2003;  23 197-205
• 71 American Academy of Pediatrics Committee on Drugs . Transfer of drugs and other chemicals into human milk.  Pediatrics. 2001;  108 776-789
• 72 Wojnar-Horton R E, Hackett L P, Yapp P, Dusci L J, Paech M, Ilett K F. Distribution and excretion of sumatriptan in human milk.  Br J Clin Pharmacol. 1996;  41 217-221
• 73 Goldszmidt E, Kern R, Chaput A, Macarthur A. The incidence and etiology of postpartum headaches: a prospective cohort study.  Can J Anaesth. 2005;  52 971-977
• 74 Stein G, Morton J, Marsh A et al.. Headaches after childbirth.  Acta Neurol Scand. 1984;  69 74-79
• 75 Marcus D A, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum.  Headache. 1999;  39 625-632
• 76 Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni G C. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.  Headache. 1993;  33 385-389
• 77 Campos C R, Yamamoto F I. Intracerebral hemorrhage in postpartum cerebral angiopathy associated with the use of isometheptene.  Int J Gynaecol Obstet. 2006;  95 151-152
• 78 Sato S, Shimizu M, Endo K, Homma M, Yamamoto T. Postpartum cerebral angiopathy-a case report the vasculopathy associated with co-administration of two vasoconstrictives, methylergometrine maleate and sumatriptan.  Rinsho Shinkeigaku. 2004;  44 96-101
• 79 Granier I, Garcia E, Geissler A, Boespflug M D, Durand-Gasselin J. Postpartum cerebral angiopathy associated with the administration of sumatriptan and dihydroergotamine: a case report.  Intensive Care Med. 1999;  25 532-534
• 80 Raroque Jr H G, Tesfa G, Purdy P. Postpartum cerebral angiopathy. Is there a role for sympathomimetic drugs?.  Stroke. 1993;  24 2108-2110
• 81 Iffy L, Zito G E, Jakobovits A A, Ganesh V, McArdle J J. Postpartum intracranial haemorrhage in normotensive users of bromocriptine for ablactation.  Pharmacoepidemiol Drug Saf. 1998;  7 167-171
• 82 Oliver C D, White S A. Unexplained fitting in three parturients suffering from postdural puncture headache.  Br J Anaesth. 2002;  89 782-785